Abstract

Background: Not only low-density lipoprotein (LDL) cholesterol but also non-high-density lipoprotein cholesterol (non-HDL-C), very low-density lipoprotein (VLDL) cholesterol (VLDL-C), and intermediate-density lipoprotein (IDL) cholesterol (IDL-C) are reported to be significant risk markers for coronary heart disease (CHD). We reported the relevance of IDL-C to Framingham risk score (F-score), but the present study addressed the relevance of IDL-C to Suita score (S-score), a risk score for coronary heart disease (CHD) developed for the Japanese individuals in addition to F-score.Methods: The cholesterol levels of lipoproteins, including triglyceride (TG)-rich lipoproteins (IDL and VLDL), were measured by an anion exchange high-performance liquid chromatography (AEX-HPLC). This study enrolled 476 men, aged mean 51 years and free of CHD and stroke.Results: Non-HDL-C, IDL-C, and VLDL-C significantly correlated with F-score and S-score. In the multiple stepwise regression analysis, IDL-C as well as body mass index (BMI) significantly correlated with both F-score and S-score in both the total subjects and the subjects without drug therapy. The multivariate logistic analysis with the model composed of BMI and IDL-C as the predictor variables demonstrated that 1 SD increase in IDL-C was an independent predictor for 10-year CHD risk >10% of F-score (OR 1.534, 95% CI 1.266–1.859, p < 0001) and that of S-score (OR 1.372, 95% CI 1.130–1.667, p = 0.0014) in the total subjects. Even in the subjects without the drug therapy, the increased IDL-C, as well as BMI, were significant predictors for 10-year CHD risk >10% of S-score as well as F-score.Conclusion: These results suggest the significant relevance of the increased IDL-C for CHD risk scores in middle-aged men free of CHD and stroke. Further investigations are needed in women and elderly subjects.

Highlights

  • METHODSA high level of serum low-density lipoprotein (LDL) cholesterol (LDL-C) is established as a primary risk factor for atherosclerotic cardiovascular disease (ASCVD), including coronary heart disease (CHD) [1,2,3]

  • The Copenhagen General Population Study reported that very low-density lipoprotein (VLDL) cholesterol (VLDL-C) explained one-half myocardial infarction risk relevant to the cholesterol levels of apolipoprotein B (ApoB)-containing lipoproteins and indicated that intermediate-density lipoprotein (IDL)-C was a stronger predictor for myocardial infarction risk [11]

  • The present study demonstrates that the increased levels of IDLC among the TG-rich lipoproteins of non-high-density lipoprotein (HDL) significantly correlated with the levels of Framingham risk score (F-score) and Suita score (S-score) independently of body mass index (BMI), and showed that the increased IDL cholesterol (IDL-C) would be a predictor for F-score and S-score 10-year CHD risk more than 10% in men free of CHD and stroke

Read more

Summary

Introduction

A high level of serum low-density lipoprotein (LDL) cholesterol (LDL-C) is established as a primary risk factor for atherosclerotic cardiovascular disease (ASCVD), including coronary heart disease (CHD) [1,2,3]. The results from subjects aged ≥30 years and free of CHD at baseline in the Framingham Heart Study suggest that non-HDL-C and VLDL-C are stronger predictors of CHD risk than LDL-C regardless of the serum TG levels, indicating that VLDL-C may play a critical role in the development of CHD [7]. Low-density lipoprotein (LDL) cholesterol and non-high-density lipoprotein cholesterol (non-HDL-C), very low-density lipoprotein (VLDL) cholesterol (VLDL-C), and intermediate-density lipoprotein (IDL) cholesterol (IDL-C) are reported to be significant risk markers for coronary heart disease (CHD). We reported the relevance of IDL-C to Framingham risk score (F-score), but the present study addressed the relevance of IDL-C to Suita score (S-score), a risk score for coronary heart disease (CHD) developed for the Japanese individuals in addition to F-score

Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call